Major Depressive Disorder

Psych Congress Poster Brief

MDD Symptom Improvements With Zuranolone Extend to Daily Lives, Responders Report

10/10/2023

Patients with MDD who responded to treatment with zuranolone said they experienced rapid improvement in depressive symptoms and in their daily lives, Psych Congress poster states.

Patients with MDD who responded...

10/10/2023

Psych Congress Network

Videos

Loneliness, Social Isolation, and Major Depressive Disorder

09/06/2023

While psychotherapy, psychosocial treatments, and psychopharmacology have been the standard treatment for major depressive disorder (MDD), social ties also play a significant role in determining whether or not patients can achieve remission.

While psychotherapy,...

09/06/2023

Psych Congress Network

News

Experts Convene in Nashville at Psych Congress 2023 to Address Rising Concerns in MDD Treatment

09/05/2023

Evi Arthur ;

Psych Congress will celebrate 36 years of delivering practical, case-based education to psychiatrists, nurse practitioners, physician assistants, and other mental health professionals, from September 6-10 in Nashville, Tennessee.

Psych Congress will celebrate 36...

09/05/2023

Psych Congress Network

Quiz

Which Treatment Outcomes Do Patients Care About The Most?

10/20/2022

Take the quiz to test your clinical knowledge!

Take the quiz to test your...

10/20/2022

Psych Congress Network

Videos

Are Non-Symptom Factors Worth Consideration When Determining Patient Treatment Response?

10/05/2022

Dr Zimmerman weighs in on the recent research that patients consider non-symptom factors important in evaluating treatment response.

Dr Zimmerman weighs in on the...

10/05/2022

Psych Congress Network

News

Cariprazine Effective Against ADT-resistant MDD

09/20/2022

Evi Arthur ;

Cariprazine could be effective in treating patients with major depressive disorder and inadequate response to antidepressant treatment.

Cariprazine could be effective...

09/20/2022

Psych Congress Network

News

Added Brexpiprazole Improves Life Engagement in Adults With Major Depression

09/18/2022

Jolynn Tumolo ;

Adjunctive brexpiprazole was associated with significant gains in patient life engagement in adults with major depressive disorder (MDD) and inadequate response to antidepressant treatment, according to a poster presented at Psych Congress.

Adjunctive brexpiprazole was...

09/18/2022

Psych Congress Network